EBF1 and B-cell chronic lymphocytic leukemia: Binding of EBF1 was lost at 826 sites and gained at 173 sites in CLL, separating malignant and NBC samples and showing a very good overlap with the ATAC analysis (Appendix Fig S8A–D).